240 related articles for article (PubMed ID: 27356725)
1. Genetic Abnormalities in Oral Leukoplakia and Oral Cancer Progression.
Kil TJ; Kim HS; Kim HJ; Nam W; Cha IH
Asian Pac J Cancer Prev; 2016; 17(6):3001-6. PubMed ID: 27356725
[TBL] [Abstract][Full Text] [Related]
2. [Detection of TP53-mutations in brush biopsies from oral leukoplakias].
Scheifele C; Schlechte H; Bethke G; Reichart PA
Mund Kiefer Gesichtschir; 2002 Nov; 6(6):410-4. PubMed ID: 12447653
[TBL] [Abstract][Full Text] [Related]
3. Short telomeres in an oral precancerous lesion: Q-FISH analysis of leukoplakia.
Aida J; Kobayashi T; Saku T; Yamaguchi M; Shimomura N; Nakamura K; Ishikawa N; Maruyama S; Cheng J; Poon SS; Sawabe M; Arai T; Takubo K
J Oral Pathol Med; 2012 May; 41(5):372-8. PubMed ID: 22122732
[TBL] [Abstract][Full Text] [Related]
4. Progress risk assessment of oral premalignant lesions with saliva miRNA analysis.
Yang Y; Li YX; Yang X; Jiang L; Zhou ZJ; Zhu YQ
BMC Cancer; 2013 Mar; 13():129. PubMed ID: 23510112
[TBL] [Abstract][Full Text] [Related]
5. Carcinoma and dysplasia in oral leukoplakias in Taiwan: prevalence and risk factors.
Lee JJ; Hung HC; Cheng SJ; Chen YJ; Chiang CP; Liu BY; Jeng JH; Chang HH; Kuo YS; Lan WH; Kok SH
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Apr; 101(4):472-80. PubMed ID: 16545712
[TBL] [Abstract][Full Text] [Related]
6. Improvement in the risk assessment of oral leukoplakia through morphology-related copy number analysis.
Li X; Liu L; Zhang J; Ma M; Sun L; Li X; Zhang H; Wang J; Huang Y; Li T
Sci China Life Sci; 2021 Sep; 64(9):1379-1391. PubMed ID: 34351567
[TBL] [Abstract][Full Text] [Related]
7. p53 expression in oral precancer and cancer.
Rich AM; Kerdpon D; Reade PC
Aust Dent J; 1999 Jun; 44(2):103-5. PubMed ID: 10452165
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of cornulin, keratin 4, keratin 13 expression and grade of dysplasia for predicting malignant progression of oral leukoplakia.
Schaaij-Visser TB; Bremmer JF; Braakhuis BJ; Heck AJ; Slijper M; van der Waal I; Brakenhoff RH
Oral Oncol; 2010 Feb; 46(2):123-7. PubMed ID: 20036603
[TBL] [Abstract][Full Text] [Related]
9. Screening for oral precancer with noninvasive genetic cytology.
Bremmer JF; Graveland AP; Brink A; Braakhuis BJ; Kuik DJ; Leemans CR; Bloemena E; van der Waal I; Brakenhoff RH
Cancer Prev Res (Phila); 2009 Feb; 2(2):128-33. PubMed ID: 19174582
[TBL] [Abstract][Full Text] [Related]
10. [Histochemical study of lectin receptor and cell morphometric analysis on oral leukoplakias, epithelial dysplasia and squamous carcinoma].
Jiang Y; Wu Y; Wang F
Zhonghua Kou Qiang Yi Xue Za Zhi; 1996 Nov; 31(6):351-3. PubMed ID: 9592290
[TBL] [Abstract][Full Text] [Related]
11. CD133 expression in oral lichen planus correlated with the risk for progression to oral squamous cell carcinoma.
Sun L; Feng J; Ma L; Liu W; Zhou Z
Ann Diagn Pathol; 2013 Dec; 17(6):486-9. PubMed ID: 23911820
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of MAGE-A expression and grade of dysplasia for predicting malignant progression of oral leukoplakia.
Ries J; Agaimy A; Vairaktaris E; Kwon Y; Neukam FW; Strassburg LH; Nkenke E
Int J Oncol; 2012 Sep; 41(3):1085-93. PubMed ID: 22751922
[TBL] [Abstract][Full Text] [Related]
13. Epidermal growth factor receptor expression and gene copy number in the risk of oral cancer.
Taoudi Benchekroun M; Saintigny P; Thomas SM; El-Naggar AK; Papadimitrakopoulou V; Ren H; Lang W; Fan YH; Huang J; Feng L; Lee JJ; Kim ES; Hong WK; Johnson FM; Grandis JR; Mao L
Cancer Prev Res (Phila); 2010 Jul; 3(7):800-9. PubMed ID: 20570883
[TBL] [Abstract][Full Text] [Related]
14. Elevated ras p21 expression in oral premalignant lesions and squamous cell carcinoma in Taiwan.
Kuo MY; Chang HH; Hahn LJ; Wang JT; Chiang CP
J Oral Pathol Med; 1995 Jul; 24(6):255-60. PubMed ID: 7562661
[TBL] [Abstract][Full Text] [Related]
15. Role of TP53 in the progression of pre-malignant and malignant oral mucosal lesions. A follow-up study of 144 patients.
Ogmundsdóttir HM; Björnsson J; Holbrook WP
J Oral Pathol Med; 2009 Aug; 38(7):565-71. PubMed ID: 19473450
[TBL] [Abstract][Full Text] [Related]
16. Accumulation of the p53 tumor-suppressor gene product in oral leukoplakia.
Wood MW; Medina JE; Thompson GC; Houck JR; Min KW
Otolaryngol Head Neck Surg; 1994 Dec; 111(6):758-63. PubMed ID: 7527509
[TBL] [Abstract][Full Text] [Related]
17. Actual proliferating index in oral squamous cell carcinoma and leukoplakia.
Chandak AR; Gadbail AR; Chaudhary MS; Chandak SA; Wadhwani R
J Investig Clin Dent; 2011 Aug; 2(3):176-83. PubMed ID: 25426788
[TBL] [Abstract][Full Text] [Related]
18. Potentially Malignant Oral Disorders and Cancer Transformation.
Ganesh D; Sreenivasan P; Öhman J; Wallström M; Braz-Silva PH; Giglio D; Kjeller G; Hasséus B
Anticancer Res; 2018 Jun; 38(6):3223-3229. PubMed ID: 29848669
[TBL] [Abstract][Full Text] [Related]
19. Stathmin! An immunohistochemical analysis of the novel marker in Oral Squamous Cell Carcinoma and Oral Leukoplakia.
Vadla P; Yeluri S; Deepthi G; Guttikonda VR; Taneeru S; Naramala S
Asian Pac J Cancer Prev; 2020 Nov; 21(11):3317-3323. PubMed ID: 33247690
[TBL] [Abstract][Full Text] [Related]
20. Use of allelic loss to predict malignant risk for low-grade oral epithelial dysplasia.
Rosin MP; Cheng X; Poh C; Lam WL; Huang Y; Lovas J; Berean K; Epstein JB; Priddy R; Le ND; Zhang L
Clin Cancer Res; 2000 Feb; 6(2):357-62. PubMed ID: 10690511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
